These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34860298)

  • 1. Relationship between vitreoretinal lymphoma and the site of lymphoma development in the central nervous system.
    Maruyama K; Iwahashi C; Hashida N; Ohguro N; Nishida K
    Jpn J Ophthalmol; 2022 Mar; 66(2):142-150. PubMed ID: 34860298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration.
    Dalvin LA; Pulido JS; Shields CL; Marchese A; Miserocchi E; Frenkel S; Pe'er J
    Eye (Lond); 2023 Jan; 37(1):54-61. PubMed ID: 34999721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
    Kim JY; Kim JJ; Kim RY; Kim M; Park YG; Park YH
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2421-2429. PubMed ID: 38446203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes.
    Fadlelseed H; Rhatigan M; Treacy M; Murphy C; O'Neill J; Kilmartin D; Kennedy S
    Pathol Res Pract; 2024 Sep; 261():155500. PubMed ID: 39106590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
    Kaburaki T; Taoka K
    Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
    Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
    Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological diagnosis of vitreoretinal lymphomas: A case series.
    Quintyn JC; Olle P; Courtade-Saidi M; Laurent C; Obéric L; Quintyn-Ranty ML
    Cytopathology; 2019 Jul; 30(4):385-392. PubMed ID: 31033057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
    Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
    Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
    Hashida N; Nakai K; Saitoh N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
    Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
    Eur J Ophthalmol; 2024 Jul; 34(4):931-940. PubMed ID: 37956540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
    Cheng CL; Yeh PT; Fang WQ; Ma WL; Hou HA; Tsai CH; Lin CP; Tien HF
    Cancer Med; 2023 Apr; 12(7):8102-8111. PubMed ID: 36602288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy.
    Gozzi F; Aldigeri R; Mastrofilippo V; De Simone L; Bolletta E; Marzano J; Iannetta D; Coassin M; Ilariucci F; Ferrari A; Luminari S; Merli F; Croci S; Zerbini A; Farnetti E; Nicoli D; Valli R; Tamagnini I; Cavazza A; Salvarani C; Fontana L; Cimino L
    Ocul Immunol Inflamm; 2022; 30(7-8):1833-1841. PubMed ID: 34379571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye involvement in primary central nervous system lymphoma.
    Farrall AL; Smith JR
    Surv Ophthalmol; 2020; 65(5):548-561. PubMed ID: 32057762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Vitreoretinal Lymphoma in B-Scan Ultrasonography: A Case-Control Study.
    Gu J; Chen Q; Zhang P; Zhang T; Zhou X; Zhang K; Jiang T; Liu S; Chen W; Zhou M; Jiang R; Huang X; Xu G; Chang Q
    Ophthalmol Retina; 2024 Mar; 8(3):264-269. PubMed ID: 37820767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of primary vitreoretinal lymphoma developing extra-central nervous system (CNS)/testicular lymphomas with or without CNS involvement: A single-centre study of 13 cases.
    Kunimi K; Usui Y; Sugawara R; Asakage M; Tsubota K; Gotoh A; Goto H
    Br J Haematol; 2023 Apr; 201(1):158-161. PubMed ID: 36693806
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.